Klabion Uno (Clarithromycin Citrate)

Clarithromycin is a macrolide antibiotic used to treat infections caused by susceptible bacteria.

• Community‑acquired pneumonia: eradicates the causative bacterial pathogens and improves respiratory symptoms.
• Acute bacterial sinusitis: reduces sinus inflammation and clears infection.
• Acute exacerbation of chronic bronchitis: shortens disease duration and relieves cough.
• Skin and soft‑tissue infections: eliminates bacterial growth and promotes healing.
• Helicobacter pylori eradication (in combination therapy): contributes to successful eradication regimens.

• Clarithromycin binds to the 50 S subunit of the bacterial ribosome, blocking the translocation step of protein synthesis. This inhibition prevents the formation of essential proteins, leading to bacterial growth arrest and eventual cell death. The drug exhibits a concentration‑dependent bacteriostatic effect against a broad spectrum of Gram‑positive and some Gram‑negative organisms.

Clarithromycin may cause several adverse reactions, ranging from mild to severe.

Common Side Effects

• Nausea: mild to moderate stomach upset.
• Diarrhea: frequent loose stools.
• Abdominal pain: cramping or discomfort.
• Taste disturbance: altered taste perception.
• Headache: mild to moderate.
• Vomiting: occasional episodes.

Serious or Rare Side Effects

• QT prolongation: potential cardiac arrhythmias.
• Severe allergic reactions: anaphylaxis or angioedema.
• Clostridioides difficile‑associated diarrhea: severe colitis.
• Hepatic dysfunction: elevated liver enzymes.
• Stevens‑Johnson syndrome: severe skin reactions.
• Cardiac toxicity: especially with interacting drugs.

Before prescribing clarithromycin, consider the following safety measures.

• Assess renal and hepatic function: adjust dose if impairment is present.
• Avoid use in patients with known macrolide hypersensitivity: risk of allergic reactions.
• Monitor QT interval in patients with cardiac risk factors: prevent arrhythmias.
• Use with caution in pregnant or breastfeeding women: limited safety data.
• Avoid concomitant use with strong CYP3A4 inhibitors: may increase drug levels.
• Store at room temperature: keep in the original container, protect from moisture and light.

Clarithromycin can interact with several medications, requiring careful management.

Major Interactions (Avoid)

• Other macrolides (e.g., erythromycin): additive risk of QT prolongation.
• Strong CYP3A4 inhibitors (e.g., ketoconazole, itraconazole): may raise clarithromycin plasma concentrations.
• Cisapride: increased risk of serious cardiac arrhythmias.
• Pimozide: heightened potential for cardiac toxicity.

Moderate Interactions (Monitor Closely)

• Warfarin: may enhance anticoagulant effect, requiring INR monitoring.
• Theophylline: possible increase in serum levels, watch for toxicity.
• Statins (e.g., lovastatin): elevated risk of myopathy, monitor muscle symptoms.